Fair Value Measurement - Additional Information (Details) $ / shares in Units, $ in Thousands		3 Months Ended	12 Months Ended
	Jun. 27, 2025 tranche $ / shares shares	Mar. 31, 2025 USD ($)	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Percentage of outstanding debt covered by swaps			50.00%
Number of days to register the resale of shares underlying warrants	45 days
Derivative Liability | $			$ 110	$ 5,701
Unamortized value of warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability | $			2,518	$ 0
Losses of debt and equity securities | $			$ (100)
Term Loan due 2030 | Domestic Line of Credit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants term	5 years
Aggregate shares of company stock (in shares) | shares	3,934,776
Number of tranches | tranche	2
Right to repurchase percentage	0.50
Term Loan due 2030 | Domestic Line of Credit | Debt Instrument, Redemption, Period One
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Right to repurchase percentage	0.50
Term Loan due 2030 | Domestic Line of Credit | Vesting period 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Exercise price (in dollars per share) | $ / shares	$ 1.52
Term Loan due 2030 | Domestic Line of Credit | Vesting period 1 | Debt Instrument, Redemption, Period One
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Exercise price (in dollars per share) | $ / shares	1.40
Term Loan due 2030 | Domestic Line of Credit | Vesting period 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Exercise price (in dollars per share) | $ / shares	2.07
Term Loan due 2030 | Domestic Line of Credit | Vesting period 2 | Debt Instrument, Redemption, Period One
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Exercise price (in dollars per share) | $ / shares	$ 1.00
Interest rate swap agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Settlement of derivative agreement | $		$ 600